Intervention Protocol

You have free access to this content

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation

  1. Lise J Estcourt1,*,
  2. Simon Stanworth1,
  3. Carolyn Doree2,
  4. Marialena Trivella3,
  5. Sally Hopewell4,
  6. Michael F Murphy5,
  7. Alan Tinmouth6

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 18 MAR 2014

DOI: 10.1002/14651858.CD010984


How to Cite

Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy MF, Tinmouth A. Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD010984. DOI: 10.1002/14651858.CD010984.

Author Information

  1. 1

    NHS Blood and Transplant, Haematology/Transfusion Medicine, Oxford, UK

  2. 2

    NHS Blood and Transplant, Systematic Review Initiative, Oxford, UK

  3. 3

    The Cochrane Collaboration, Cochrane Editorial Unit, Oxford, UK

  4. 4

    University of Oxford, Centre for Statistics in Medicine, Oxford, Oxfordshire, UK

  5. 5

    John Radcliffe Hospital, NHS Blood and Transplant, Oxford, UK

  6. 6

    The Ottawa Health Research Institute and the University of Ottawa, Medicine (hematology) and Pathology Centre for Transfusion Research, Ottawa, Ontario, Canada

*Lise J Estcourt, Haematology/Transfusion Medicine, NHS Blood and Transplant, Level 2, John Radcliffe Hospital, Headington, Oxford, OX3 9BQ, UK. lise.estcourt@nhsbt.nhs.uk. lestcourt@doctors.org.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 18 MAR 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine whether different doses of prophylactic platelet transfusions (platelet transfusions given to prevent bleeding) affect their efficacy and safety in preventing bleeding in patients with haematological disorders after chemotherapy with or without stem cell transplantation.